ASP Isotopes (NASDAQ:ASPI) Shares Up 8% – Here’s What Happened

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) shot up 8% on Friday . The company traded as high as $4.54 and last traded at $4.5460. 510,470 shares changed hands during trading, a decline of 90% from the average session volume of 5,182,098 shares. The stock had previously closed at $4.21.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Trading Up 6.4%

The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14. The stock has a fifty day moving average of $5.12 and a 200 day moving average of $6.90. The company has a market capitalization of $496.56 million, a PE ratio of -2.09 and a beta of 3.59.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Friday, April 10th. The company reported ($0.84) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.70). ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%.The firm had revenue of $33.32 million during the quarter, compared to the consensus estimate of $2.03 million. As a group, sell-side analysts predict that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, COO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $5.44, for a total value of $45,902.72. Following the sale, the chief operating officer owned 1,537,817 shares of the company’s stock, valued at $8,365,724.48. The trade was a 0.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 14.40% of the stock is currently owned by insiders.

Institutional Trading of ASP Isotopes

A number of large investors have recently added to or reduced their stakes in ASPI. Quantbot Technologies LP bought a new stake in ASP Isotopes in the 3rd quarter worth approximately $34,000. BNP Paribas Financial Markets increased its stake in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after acquiring an additional 2,548 shares during the last quarter. IFP Advisors Inc bought a new stake in ASP Isotopes in the 4th quarter worth approximately $48,000. Pictet Asset Management Holding SA bought a new stake in ASP Isotopes in the 4th quarter worth approximately $61,000. Finally, Close Asset Management Ltd bought a new stake in ASP Isotopes in the 3rd quarter worth approximately $72,000. Institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.